Grace Therapeutics, Inc. (GRCE) Insider Trading

Name: Grace Therapeutics, Inc. (GRCE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 1, 2026): Opaleye Management Inc. (10% Owner): Purchase of 7,849 shares, $16.4K.

Get alerted when insiders trade GRCE

Email address

Loading company data...

Beta

Loading company details...

Beta